Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 27.09 CNY -1.67% Market Closed
Market Cap: 40.3B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Pharmaron Beijing Co Ltd

Current Assets 7.1B
Cash & Short-Term Investments 2.7B
Receivables 2.9B
Other Current Assets 1.5B
Non-Current Assets 15.9B
Long-Term Investments 968m
PP&E 10.4B
Intangibles 3.6B
Other Non-Current Assets 953.7m
Current Liabilities 3.9B
Accounts Payable 503m
Accrued Liabilities 732.6m
Short-Term Debt 556.1m
Other Current Liabilities 2.1B
Non-Current Liabilities 6.1B
Long-Term Debt 4.8B
Other Non-Current Liabilities 1.3B

Balance Sheet
Pharmaron Beijing Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
75
462
294
321
4 460
2 935
3 527
1 448
5 791
Cash
0
0
0
0
0
0
2 770
0
5 791
Cash Equivalents
75
462
294
321
4 460
2 935
757
1 448
0
Short-Term Investments
0
0
0
0
183
910
2 634
1 308
774
Total Receivables
273
461
645
784
1 111
1 357
1 689
2 512
3 007
Accounts Receivables
249
391
543
655
946
1 210
1 424
2 214
2 636
Other Receivables
24
70
102
129
165
147
265
298
371
Inventory
48
93
93
120
157
282
680
1 041
1 013
Other Current Assets
39
81
46
50
33
57
113
227
289
Total Current Assets
435
1 097
1 078
1 275
5 944
5 540
8 644
6 536
10 874
PP&E Net
501
742
2 094
2 555
2 882
3 799
5 811
8 464
10 062
PP&E Gross
501
742
2 094
2 555
2 882
3 799
5 811
8 464
10 062
Accumulated Depreciation
272
346
476
718
1 008
1 339
1 672
2 166
3 008
Intangible Assets
21
22
302
390
421
566
693
803
789
Goodwill
0
0
134
140
203
1 166
2 096
2 688
2 781
Long-Term Investments
5
3
49
141
236
446
763
1 008
1 005
Other Long-Term Assets
212
940
262
299
248
392
383
994
965
Other Assets
0
0
134
140
203
1 166
2 096
2 688
2 781
Total Assets
1 175
N/A
2 805
+139%
3 919
+40%
4 801
+23%
9 935
+107%
11 909
+20%
18 389
+54%
20 493
+11%
26 477
+29%
Liabilities
Accounts Payable
41
61
92
108
118
191
316
406
412
Accrued Liabilities
88
105
138
211
290
472
626
785
806
Short-Term Debt
170
211
275
382
214
377
422
663
577
Current Portion of Long-Term Debt
38
99
197
176
130
93
156
239
336
Other Current Liabilities
627
185
240
431
518
848
1 463
1 819
1 524
Total Current Liabilities
965
661
941
1 308
1 270
1 982
2 982
3 912
3 654
Long-Term Debt
26
366
893
1 044
675
581
4 708
5 215
8 902
Deferred Income Tax
0
0
11
22
41
107
173
261
290
Minority Interest
0
0
13
13
71
63
166
291
681
Other Liabilities
15
14
64
101
112
305
231
264
392
Total Liabilities
1 006
N/A
1 041
+3%
1 922
+85%
2 488
+29%
2 168
-13%
3 038
+40%
8 260
+172%
9 944
+20%
13 920
+40%
Equity
Common Stock
131
591
591
591
794
794
794
1 191
1 787
Retained Earnings
70
49
279
602
1 078
2 131
3 554
4 574
5 818
Additional Paid In Capital
107
1 129
1 129
1 129
5 965
6 028
6 008
5 254
5 222
Treasury Stock
0
0
0
0
73
45
302
668
463
Other Equity
0
5
1
9
2
38
74
197
194
Total Equity
168
N/A
1 763
+949%
1 998
+13%
2 313
+16%
7 767
+236%
8 870
+14%
10 129
+14%
10 549
+4%
12 557
+19%
Total Liabilities & Equity
1 175
N/A
2 805
+139%
3 919
+40%
4 801
+23%
9 935
+107%
11 909
+20%
18 389
+54%
20 493
+11%
26 477
+29%
Shares Outstanding
Common Shares Outstanding
131
591
591
591
924
924
1 773
1 772
1 773

See Also

Discover More